Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cullinan Therapeutics (CGEM) Non-Current Assets (2020 - 2023)

Historic Non-Current Assets for Cullinan Therapeutics (CGEM) over the last 4 years, with Q3 2023 value amounting to $18.0 million.

  • Cullinan Therapeutics' Non-Current Assets fell 4882.26% to $18.0 million in Q3 2023 from the same period last year, while for Sep 2023 it was $244.3 million, marking a year-over-year decrease of 2713.47%. This contributed to the annual value of $86.6 million for FY2022, which is 3838.4% down from last year.
  • Cullinan Therapeutics' Non-Current Assets amounted to $18.0 million in Q3 2023, which was down 4882.26% from $23.7 million recorded in Q2 2023.
  • Cullinan Therapeutics' 5-year Non-Current Assets high stood at $140.6 million for Q4 2021, and its period low was $2.4 million during Q4 2020.
  • Its 4-year average for Non-Current Assets is $71.6 million, with a median of $65.5 million in 2022.
  • Its Non-Current Assets has fluctuated over the past 5 years, first surged by 568687.24% in 2021, then plummeted by 7177.24% in 2022.
  • Cullinan Therapeutics' Non-Current Assets (Quarter) stood at $2.4 million in 2020, then surged by 5686.87% to $140.6 million in 2021, then crashed by 38.38% to $86.6 million in 2022, then plummeted by 79.23% to $18.0 million in 2023.
  • Its last three reported values are $18.0 million in Q3 2023, $23.7 million for Q2 2023, and $116.0 million during Q1 2023.